Dimensional Fund Advisors LP Satsuma Pharmaceuticals, Inc. Transaction History

Dimensional Fund Advisors LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.61 - $5.06 $27,357 - $226,935	-44,849 Reduced 16.23%	231,417 $208,000
Q3 2022 Nov 10, 2022	BUY	$4.19 - $7.95 $166,472 - $315,861	39,731 Added 16.8%	276,266 $1.66 Million
Q2 2022 Aug 12, 2022	BUY	$2.59 - $4.3 $43,177 - $71,685	16,671 Added 7.58%	236,535 $979,000
Q1 2022 May 13, 2022	BUY	$3.78 - $5.32 $64,940 - $91,397	17,180 Added 8.48%	219,864 $835,000
Q4 2021 Feb 09, 2022	SELL	$4.15 - $6.24 $124,827 - $187,692	-30,079 Reduced 12.92%	202,684 $912,000
Q3 2021 Nov 12, 2021	BUY	$4.54 - $7.17 $248,633 - $392,665	54,765 Added 30.77%	232,763 $1.09 Million
Q2 2021 Aug 12, 2021	BUY	$4.8 - $7.25 $603,576 - $911,651	125,745 Added 240.65%	177,998 $1.26 Million
Q1 2021 May 14, 2021	BUY	$4.57 - $7.18 $238,796 - $375,176	52,253 New	52,253 $309,000

Ticker STSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,587,500
Description
Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can ...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.